Summary: “Society has started to become more accepting of our work and MAPS’ goal of mainstreaming psychedelic medicine seems closer than ever to being achieved,” explains MAPS Policy and Advocacy Director Natalie Ginsberg, M.S.W., in an interview with Jessica Semaan of Seismic Sisters. During the interview, Ginsberg shares her perspectives about the shift in acceptance towards the therapeutic potential of psychedelics, expresses her passion for drug policy, and explains what led her to work at MAPS.
Originally appearing here.